Denis Shafranik
Partner & Co-Founder @ Concentric
London, United Kingdom
Denis Shafranik is a seed investor at Concentric in London focused on Internet and Health Care. Denis Shafranik is co-founder of Concentric; an activist venture fund with a focus on partnering with early-stage software businesses augmenting real economy sectors. Denis Shafranik spent 9 years in investment banking. He graduated from the London School of Economics, obtained an EMBA from INSEAD, and is a CFA charter.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 52%
Last updated:
For AI agents: llms.txt
Industries Denis Shafranik invests in
Stages Denis Shafranik invests in
Countries Denis Shafranik invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Internet 3 (9%)
- Health Care 3 (9%)
- Retail 2 (6%)
- Billing 2 (6%)
- FinTech 2 (6%)
Stage
- Seed 9 (27%)
- Series A 7 (21%)
- Series B 5 (15%)
- Funding Round 2 (6%)
- Convertible Note 1 (3%)
Country
- United Kingdom 8 (24%)
- Germany 2 (6%)
- Chile 1 (3%)
- Brazil 1 (3%)
- Mexico 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Visium is a consulting company specialized in artificial intelligence, machine learning, and consulting. It delivers value to companies at every level of AI development, whether they are just entering the field or have a solid data science department. The company was founded in 2018 and headquartered in Zurich, Switzerland. | May 20, 2026 | ||
| Transcend Therapeutics is a clinical-stage biotechnology company focused on developing rapid-acting treatments for neuropsychiatric diseases. The company aims to address mental health conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), particularly for patients who do not respond to existing therapies. Thecompany’s lead program, TSND-201 (methylone), is being developed as a next-generation neuroplastogen designed to deliver fast and durable therapeutic effects. Its research emphasizes innovative psychoactive compounds that can improve outcomes while minimizing common limitations of traditional psychiatric medications. Backed by venture funding and an experienced leadership team with multiple FDA approvals, Transcend Therapeutics continues to advance clinical trials and expand its pipeline of mental health treatments. | Convertible Note / Oct 28, 2024 | ||
| Koywe provides payment APIs and SDKs so that any company can start leveraging crypto to offer remittances, wallets, and investment services. | $5M / Seed / Aug 01, 2024 | ||
| Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. | $40M / Jan 04, 2024 | ||
| Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $54.8M / Series B / Jan 09, 2023 | ||
| Higher Education - Art, Design | $11M / Series A / Nov 01, 2021 | ||
| Merama is an e-commerce platform that partners and exponentiates the growth of each brand they work with. The platform helps fuel their business with outstanding human resources and non-dilutive capital. Its mission is to be the best and largest online group of brands in Latin America.Merama was founded in 2020 and is headquartered in MexicoCity, Mexico. | $225M / Series B / Sep 28, 2021 | ||
| Pockit is a fintech business that focuses on providing financial services primarily to customers who are typically excluded or at least underserved by high street banks. It provides a digital banking app designed to cater to the underbanked masses. | $20.2M / Series B / Dec 03, 2020 | ||
| Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $11M / Series A / Oct 29, 2020 | ||
| Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $10.4M / Series A / Feb 26, 2020 | ||
| See all 33 investments → | |||
Co-Investors
About Concentric
We partner with sector-defining founders across Europe to create new technologies that disrupt the status quo and solve the problems that matter. Powered by a relentlessly driven ethos that never stops seeking to push boundaries, we foster deeper, actively personal relationships with our partners that drive opportunity, innovation and scale. As a network of hands-on experts – we’re united by a progressive world-view and a pioneering ambition to make a difference. While our fluid, open approach to each opportunity helps make sure we’re able to bring a bespoke service to every single member of our diverse and dynamic portfolio.
Concentric Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Kjartan Rist
Founding Partner
|
|||
Alexander Mann
Principal
|
|||
Alexander Stroud
Principal
|
|||
|
Denis Shafranik
Partner & Co-Founder
|
|||
Ilya Belyaev
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Denis Shafranik invest in?
Denis Shafranik invests primarily in Internet, Health Care and Retail startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Denis Shafranik?
Public channels for Denis Shafranik include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Denis Shafranik last invest?
The most recent investment recorded for Denis Shafranik closed in May 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
